Literature DB >> 20931288

Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.

Rene Nkoulou1, Aju P Pazhenkottil, Ronny R Buechel, Lars Husmann, Ines Valenta, Bernhard A Herzog, Mathias Wolfrum, Jelena R Ghadri, Philipp A Kaufmann.   

Abstract

SPECT myocardial perfusion imaging (MPI) is commonly used for comprehensive interpretation of metabolic PET FDG imaging in ischemic dysfunctional myocardium. We evaluated the difference in scan interpretation introduced by CT attenuation correction (CTAC) of SPECT MPI in patients undergoing viability characterization by (99m)Tc SPECT MPI/PET FDG. In 46 consecutive patients (mean age 64, range 36-83 years) with dysfunctional myocardium, we analyzed viability from combined SPECT MPI and PET FDG scanning without attenuation correction (NC) and with CTAC for SPECT MPI. FDG uptake was classified in groups of percent uptake using the segment with maximum tracer in SPECT perfusion uptake as reference. Viability patterns were categorized as normal, mismatch, mild match and scar by relative comparison of SPECT and PET. Applying CTAC introduced a different reference segment for the normalization of PET FDG study in 57% of cases. As a result, the flow-metabolism pattern changed in 28% of segments, yielding a normal, mismatch, mild match and scar pattern in 462, 150, 123, and 47 segments with NC and 553, 86, 108, and 35 with CTAC, respectively (P = 0.001). Thus, by introducing CTAC for SPECT MPI 25% of segments originally classified as scar were reclassified and the number of normal segments increased by 20%. Introducing CTAC decreased by 54% the number of patients with possible indication for revascularization, from 26/46 to 12/46 (P < 0.001). Different interpretation of myocardial viability can be observed when using CTAC instead of NC SPECT MPI as reference for PET FDG scans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20931288     DOI: 10.1007/s10554-010-9719-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  29 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Waren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

2.  Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation.

Authors:  Yasmin Masood; Yi-Hwa Liu; Gordon Depuey; Raymond Taillefer; Luis I Araujo; Steven Allen; Dominique Delbeke; Frank Anstett; Aharon Peretz; Mary-Jo Zito; Vera Tsatkin; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

3.  Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.

Authors:  Riemer H J A Slart; Jeroen J Bax; Wim J Sluiter; Dirk J van Veldhuisen; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

4.  Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.

Authors:  J vom Dahl; C Altehoefer; F H Sheehan; P Buechin; G Schulz; E R Schwarz; K C Koch; R Uebis; B J Messmer; U Buell; P Hanrath
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

Review 5.  Assessment of myocardial viability in patients with heart failure.

Authors:  Arend F L Schinkel; Don Poldermans; Abdou Elhendy; Jeroen J Bax
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

6.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

7.  Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction.

Authors:  V Rizzello; D Poldermans; E Biagini; A F L Schinkel; E Boersma; A Boccanelli; T Marwick; J R T C Roelandt; J J Bax
Journal:  Heart       Date:  2009-05-13       Impact factor: 5.994

8.  Effects of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction.

Authors:  M Galli; C Marcassa; A Imparato; R Campini; P S Orrego; P Giannuzzi
Journal:  Am J Cardiol       Date:  1994-11-01       Impact factor: 2.778

9.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  R S Beanlands; P J Hendry; R G Masters; R A deKemp; K Woodend; T D Ruddy
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

10.  Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting.

Authors:  A S Iskandrian; A H Hakki; S A Kane; I P Goel; E D Mundth; A H Hakki; B L Segal
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

View more
  5 in total

1.  Prognostic value of revascularising viable myocardium in elderly patients with stable coronary artery disease and left ventricular dysfunction: a PET/CT study.

Authors:  Mehdi Namdar; Olivier Rager; Julien Priamo; Angela Frei; Stephane Noble; Gael Amzalag; Osman Ratib; René Nkoulou
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-28       Impact factor: 2.357

2.  Hypodense regions in unenhanced CT identify nonviable myocardium: validation versus 18F-FDG PET.

Authors:  Tobias A Fuchs; Jelena R Ghadri; Julia Stehli; Catherine Gebhard; Egle Kazakauskaite; Bernd Klaeser; Oliver Gaemperli; Michael Fiechter; Philipp A Kaufmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-28       Impact factor: 9.236

3.  Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and ¹⁸F-FDG PET.

Authors:  Sebastian Lehner; Christian Sussebach; Andrei Todica; Christopher Uebleis; Stefan Brunner; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Marcus Hacker
Journal:  J Nucl Cardiol       Date:  2014-03-15       Impact factor: 5.952

4.  The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.

Authors:  Christopher Uebleis; Stefan Hellweger; Rüdiger Paul Laubender; Alexander Becker; Hae-Young Sohn; Sebastian Lehner; Alexander Haug; Peter Bartenstein; Paul Cumming; Serge D Van Kriekinge; Piotr J Slomka; Marcus Hacker
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

Review 5.  Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging.

Authors:  Ricardo A Costa; Hiram G Bezerra; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2012-03       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.